GSK Wins FDA Approval for Nuvalent-Acquired Nelkarmi in Lung CancerZacks Investment Research • Wednesday
GSK Accelerates Late-Stage Studies as It Targets COPD and Long-Acting Respiratory TreatmentsMarketBeat • 11/09/26
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision MedicineGlobeNewsWire • 11/03/26
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth?Zacks Investment Research • 10/29/26
GSK plc (GSK) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress TranscriptSeeking Alpha • 10/27/26
GSK, Hansoh's bone cancer drug delays disease progression in late-stage China studyReuters • 10/26/26